Skip to main content
MOH logo

MOH · Molina Healthcare, Inc. · Financials

Track MOH — free
$216.64 -9.78 (-4.32%) At close · Nov 5 Play latest call Q3 2026 earnings call transcript
Market Cap
$11.82B
Shares
52.20M
Volume · Nov 5 928.01K Avg daily vol (3M) 745.72K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Revenue
$45.43B +11.7%
FY2025 Revenue FY2009–FY2025
Net Income
$472M -60%
FY2025 Net Income FY2009–FY2025
Gross Margin
13.07% -2.2pp
FY2025 Gross Margin FY2013–FY2025
Operating Margin
1.72% -2.5pp
FY2025 Operating Margin FY2009–FY2025
Diluted EPS
$8.92 -56.3%
FY2025 Diluted EPS FY2009–FY2025
Operating Cash Flow
-$535M -183.1%
FY2025 Operating Cash Flow FY2009–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2029 (G) FY2027 (G) FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
$64B $46.5B $42B $44.13B $45.43BG $40.65B $34.07BG $31.97BG $27.77BG $19.42BG $16.83B $18.89B $19.88B $17.78B $14.18B $9.67B $6.59B $5.91B $4.54B $4.09B $3.67B
— — — — — — — $75M $77M $17M $17M $125M $70M $38M $23M $20M $7M $5.08M $5.45M $6.26M $9.15M
— — — $41.59B $43.05B $38.63B $32.53B $30.88B $26.86B $18.3B $16.21B $17.61B $18.85B $16.45B — — — — — — —
— — — — — — — — — — — — — — — — — $9.37M $547K $0 —
— — — $38.57B $39.49B $34.43B $28.67B $27.18B $23.7B $15.82B $13.91B — — — — — — — — — —
— — — $5.56B $5.94Bd $6.22Bd $5.4Bd $4.8Bd $4.07Bd $2.48B $2.3B $2.52B $1.81B $1.73B $1.53B $1B $843M — — — —
— — — — 13.07%d 15.31%d 15.86%d 15.01%d 14.64%d 12.76% 13.68% 13.33% 9.1% 9.7% 10.77% 10.34% 12.79% — — — —
— — — $3.01B $3.01B $2.74B $2.46B $2.31B $2.07B $1.48B $1.3B $1.33B $1.59B $1.39B $1.15B $765M $666M $518.62M $393.45M $345.99M $276.03M
— — — — $91M $82M $85M $77M $49M $15M $18M $21M $31M $32M $17M $18M $18M $20.18M $17.45M $18.47M $12.94M
— — — $161M $195M $186M $171M $176M $131M $88M $89M $127M $178M $182M $126M $134M $94M $78.76M $74.38M $60.77M $38.11M
— — — — — — — — — — — $8M $150M — — — — — — — —
— — — $43.96B $44.65B $38.94B $32.5B $30.8B $26.75B $18.35B $15.79B $17.76B $20.44B $17.48B $13.79B $9.47B $6.45B $5.87B $4.4B $3.98B $3.62B
— — — $172M $781M $1.71B $1.57B $1.17B $1.02B $1.08B $1.04B $1.13B -$555M $306M $387M $193M $137M $41.09M $135.82M $105M $51.93M
— — — — 1.72% 4.2% 4.62% 3.67% 3.67% 5.55% 6.2% 5.99% -2.79% 1.72% 2.73% 2% 2.08% 0.69% 2.99% 2.57% 1.42%
— — — $333M $976M $1.89B $1.74B $1.35B $1.15B $1.17B $1.13B $1.26B -$377M $488M $513M $327M $231M $119.86M $210.2M $165.77M $90.04M
— — — $213M $192M $118M $109M $110M $120M $102M $87M $115M $118M $101M $66M $57M $52M $16.77M $15.52M $15.51M $13.78M
— — — — — — -$109M -$110M -$145M -$117M -$72M -$132M -$57M -$101M -$65M -$58M -$56M -$17.71M -$15.52M -$15.51M —
— — — -$41M $589M $1.59B $1.46B $1.06B $875M $961M $972M $999M -$612M $205M $322M $135M $81M $23.38M $120.3M $89.49M $38.16M
— — — $7M $117M $410M $373M $271M $216M $288M $235M $292M -$100M $153M $179M $73M $36M $10.51M $42.91M $34.52M $7.29M
— — — -$48M $472M $1.18B $1.09B $792M $659M $673M $737M $707M -$512M $52M $143M $62M $53M $9.79M $20.82M $54.97M $30.87M
— — — — 1.04% 2.9% 3.2% 2.48% 2.37% 3.46% 4.38% 3.74% -2.58% 0.29% 1.01% 0.64% 0.8% 0.17% 0.46% 1.35% 0.84%
— — — -$152M $544M $1.2B $1.17B $637M $617M $706M $749M $705M -$515M $54M $140M $62M $52M $10.74M $21.61M $54.59M $31.37M
USD/shares — — — -$0.60 $8.93 $20.52 $18.91 $13.72 $11.40 $11.40 $11.85 $11.57 -$9.07 $0.93 $2.75 $1.33 $1.16 $0.21 $0.45 $1.34 $0.80
USD/shares — $4.50 at least $2.38 -$0.60 $8.92G $20.42G $18.77G $13.55G $11.25G $11.23G $11.47 $10.61 -$9.07 $0.92 $2.58 $1.29 $1.13 $0.21 $0.45 $1.32 $0.79
shares — — — — 52.8M 57.4M 57.7M 57.8M 57.8M 59M 62.2M 61.1M 56.4M 55.4M 52M 47M 46M 46.38M 45.76M 41.17K 38.77M
shares — — — — 52.9M 57.7M 58.1M 58.5M 58.6M 59.9M 64.2M 66.6M 56.4M 56.2M 56M 48M 47M 47M 46.43M 41.63K 38.98M
d Gross profit for periods the company did not report it, or tagged its operating income as gross profit, is Revenue − Cost of Revenue. Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2009–FY2025: $3.27B in buybacks.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent finance lease liabilities 2026-06-30 USD 184,000,000 10-Q filed 2026-07-23
Noncurrent debt carrying amount 2026-06-30 USD 3,769,000,000 10-Q filed 2026-07-23
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
—
Peer median 0.32×
EV/EBIT
—
Peer median 18.00×
P/E (TTM)
—
Peer median 24.30×
Price/Sales (TTM)
0.27×
Peer median 0.34×
Price/Book
2.84×
Peer median 2.61×

Peer medians compare against the 9 similar-size Healthcare Plans companies (of 13 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Medicare $1,566,000,000 $4,227,000,000 $3,824,000,000 $3,379,000,000 $2,529,000,000 $2,265,000,000 — —
Health Plans — — — — — — $18,471,000,000 $19,352,000,000
Marketplace — $2,062,000,000 $2,296,000,000 $3,091,000,000 $1,677,000,000 $1,538,000,000 — —
Medicaid — $27,707,000,000 $25,783,000,000 $21,231,000,000 $15,217,000,000 $13,026,000,000 — —
Other Program — $76,000,000 $71,000,000 $70,000,000 $0 $0 — —
All Other Segments — — — — — — $419,000,000 $531,000,000
Key facts CIK 1179929 CUSIP 60855R100 13F (30d) 255 filings 225 filers Visit website Investor relations